Faculty Spotlight: Paul Belliveau, PharmD

Alma Mater: University of Rhode Island (BS Pharmacy); MCPHS University – Boston (PharmD)

Post-Graduate Training: Clinical Pharmacy Fellowship in Antibiotic Management at Hartford Hospital

Position at MCPHS: Associate Dean – School of Pharmacy Worcester/Manchester; Fellowship Faculty Coordinator – Academics (Worcester/Manchester); Faculty Mentor for MCPHS/Pfizer fellows

What is your favorite part of working with the fellowship program?

I most enjoy providing individual mentorship to the fellows for aspects of their training that may be less emphasized by the industry partners. The fellows seem to appreciate the individualized attention and the different perspectives that we can bring as academics.

Do you have any advice for current or incoming fellows?

I would suggest keeping a focus on the fact that this is a training period. This is all about their growth and they should be cognizant of their individual goals. It is also important to consider that much growth is experienced through discomfort and when engaging in activities that may not necessarily be “their cup of tea”. Be open to opportunities, and do everything to ensure that there is follow-through on all activities from the academic and industry side.

What are some projects you’ve worked on with fellows over the years?

o   Durand, C., Bylo, M., Howard, B., & Belliveau, P. (2017). Vancomycin Dosing in Obese Patients: Special Considerations and Novel Dosing Strategies. Annals of Pharmacotherapy. First Published December 21, 2017; https://doi.org/10.1177/1060028017750084.

o   Mattox, J., Belliveau, P., & Durand, C. (2016). Oritavancin: a novel lipoglycopeptide. Consultant Pharmacist, 31, 86-95.

o   McDaneld, P.M., Spooner, L.M., Mohr, J.F., & Belliveau, P.P. (2013). Use of Daptomycin to Treat infections with methicillin-resistant staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mL. The Annals of Pharmacotherapy, 47, 1654–65.  

o   Foote, B.S., Spooner, L.M., & Belliveau, P.P. (2011). Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C. The Annals of Pharmacotherapy, 45, 1085-93.

o   Larson, K.C., Belliveau, P.P., & Spooner, L.M.  (2011). Tigecycline for the treatment of severe Clostridium difficile infection.  The Annals of Pharmacotherapy, 45, 1005-10.

o   Mitrano, J.A., Spooner, L.M., & Belliveau, P. (2009). Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation:  safety in breastfeeding infants. Pharmacotherapy, 29, 1103-9.

o   Gaffney, M.M., Belliveau, P.P., & Spooner, L.M. (2009). Apricitabine: A novel nucleoside reverse transcriptase inhibitor for HIV infection. The Annals of Pharmacotherapy, 43, 1676-83.

o   Chan, K., Kanaan, A.O., Belliveau, P.P. (2019, December). Assessing the association between student performance on the Pharmacy Curriculum Outcomes Assessment (PCOA) and North American Pharmacist Licensure Examination (NAPLEX) Readiness Exams. American Society of Health-System Pharmacists. Annual Midyear Clinical Meeting. Fellow Poster Presentation.

o   Efimova, E., Bhatnagar, B., Mattox, J., Craig, A., & Belliveau, P. (2016, December). Survey on Reconstitution of Freeze-Dried Vials in Pharmacy Practice in the United States. American Society of Health-System Pharmacists. Annual Midyear Clinical Meeting.

o   Craig, A., Mattox, J., Foster, T., Carey, K., & Belliveau, P. (2015, December). Mock Signal Evaluation– A longitudinal project designed to enhance student understanding of how a clinical skill set can be transferred to a real pharmaceutical industry activity. American Society of Health-System Pharmacists. Annual Mid-Year Clinical Meeting. Resident Poster Presentation.